Insufficient scRNA-seq data for expression of TAF1L at single-cell level.
Insufficient scRNA-seq data for expression of TAF1L at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| blood vessel | 75% | 2.83 | 1004 / 1335 | 0% | 0 | 0 / 0 |
| thymus | 75% | 2.78 | 489 / 653 | 0% | 0 | 0 / 605 |
| uterus | 75% | 2.76 | 127 / 170 | 0% | 0 | 0 / 459 |
| adipose | 74% | 2.55 | 891 / 1204 | 0% | 0 | 0 / 0 |
| ovary | 74% | 3.29 | 133 / 180 | 0% | 0 | 0 / 430 |
| skin | 73% | 2.63 | 1322 / 1809 | 0% | 0.00 | 1 / 472 |
| bladder | 71% | 2.62 | 15 / 21 | 0% | 0 | 0 / 504 |
| breast | 71% | 2.59 | 326 / 459 | 0% | 0.01 | 3 / 1118 |
| lung | 68% | 2.31 | 393 / 578 | 1% | 0.01 | 6 / 1155 |
| intestine | 68% | 2.27 | 654 / 966 | 0% | 0 | 0 / 527 |
| esophagus | 66% | 2.25 | 955 / 1445 | 1% | 0.01 | 1 / 183 |
| adrenal gland | 65% | 2.13 | 167 / 258 | 0% | 0 | 0 / 230 |
| muscle | 64% | 2.15 | 511 / 803 | 0% | 0 | 0 / 0 |
| spleen | 62% | 2.02 | 149 / 241 | 0% | 0 | 0 / 0 |
| stomach | 60% | 1.87 | 216 / 359 | 0% | 0 | 0 / 286 |
| prostate | 60% | 1.94 | 147 / 245 | 0% | 0 | 0 / 502 |
| brain | 58% | 2.19 | 1540 / 2642 | 0% | 0.01 | 1 / 705 |
| pancreas | 57% | 1.65 | 186 / 328 | 0% | 0 | 0 / 178 |
| kidney | 54% | 1.46 | 48 / 89 | 0% | 0.00 | 1 / 901 |
| heart | 52% | 1.49 | 447 / 861 | 0% | 0 | 0 / 0 |
| liver | 45% | 1.06 | 101 / 226 | 0% | 0 | 0 / 406 |
| peripheral blood | 42% | 1.26 | 389 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0051123 | Biological process | RNA polymerase II preinitiation complex assembly |
| GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
| GO_0006338 | Biological process | chromatin remodeling |
| GO_0007140 | Biological process | male meiotic nuclear division |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0005575 | Cellular component | cellular_component |
| GO_0005669 | Cellular component | transcription factor TFIID complex |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0003677 | Molecular function | DNA binding |
| GO_0070577 | Molecular function | lysine-acetylated histone binding |
| GO_0017025 | Molecular function | TBP-class protein binding |
| GO_0004402 | Molecular function | histone acetyltransferase activity |
| GO_0016251 | Molecular function | RNA polymerase II general transcription initiation factor activity |
| GO_0004674 | Molecular function | protein serine/threonine kinase activity |
| Gene name | TAF1L |
| Protein name | Transcription initiation factor TFIID subunit 1-like (TAF(II)210) (TBP-associated factor 1-like) (TBP-associated factor 210 kDa) (Transcription initiation factor TFIID 210 kDa subunit) |
| Synonyms | |
| Description | FUNCTION: May act as a functional substitute for TAF1/TAFII250 during male meiosis, when sex chromosomes are transcriptionally silenced. . |
| Accessions | ENST00000242310.4 Q8IZX4 |